REUTEMAN-FOWLER, C. Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme. In Psychiatria pre prax. Psychiatria pre prax 9. ročník : 22. - 24. november 2024, Tatranská Lomnica : odborný program a abstrakty, 2024, roč. 25, č. S2, s. 41-42. ISSN 1337-446X. Bratislava : SOLEN, 2024.